Official UK procurement notice
Urgent Palliative Care Medicines Cheshire West
Authority: NHS Cheshire and Merseyside Integrated Care Board (Central government)
What is being bought
Published requirement descriptionThe demand for palliative care drugs can be urgent and/or unpredictable. A number of the drugs used in palliative care are rarely used in other circumstances and are therefore often not widely available in community pharmacies. The stock held for the Urgent Palliative Care Medicine Service should be over and above the core stock holding and the ICB agrees to reimburse contractors should this medicine be held beyond the expiry date.
The Service provider is expected to order and continuously hold the range and quantity of stock specified for the total number of hours the pharmacy is open, including bank holiday and rotas and during any periods of locum cover.
Payment Details
- £201.80 annual fee for providing full and continuous service as outlined in the service specification and irrespective of the number of prescriptions dispensed.
- The fee will be paid in four instalments of £50.45 on the completion of the quarterly audit.
- The commissioner has the discretion to withhold quarterly payments where the commissioned service provider fails to/is unable to, respond to the commissioner's assistance, including early termination of a contract for repeated transgressions.
- The pharmacy is expected to carry out good stock management and on the rare occasions when medicines on the approved list expire, Cheshire West Place will reimburse the Drug Tariff or cost price of stock that reaches its expiry date.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to…Awarded
NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to Local Pharmacists within Cheshire West Cheshire and Merseyside ICB. The contract commenced on 1st April 2024 and will expire on the 31st March 2025 with an estimated combined Cheshire West Indicative annual contract value of
£ 1,816,20 for the selected pharmacists to participate in this scheme. The reimbursement of palliative care drugs is funded separately.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 29 Apr 2025, 18:55 BST
- Last source update
- 29 Apr 2025, 18:55 BST
- Authority reference
24-25-QYG-27D-02F-Palliative Care- FTS notice number
2025/S 000-017775- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0509a1Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. On the 12th March 2024 the Finance, Investment, Resources Committee approved this decision. Two committee members has a standing declaration of interest. The decision to award was made in line with the conflict of interest policy.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Rowlands PharmacyUrgent Palliative Care Medicines | £201 † | — | Awarded |
| Wells PharmacyUrgent Palliative Care Medicines | £201 †same award published again · counted once | — | Awarded |
| Well PharmacySMEUrgent Palliative Care Medicines | £201 † | — | Awarded |
| Wells PharmacyUrgent Palliative Care Medicines | £201 † | — | Awarded |
Contracts
Urgent Palliative Care Medicines · Rowlands Pharmacy
- Signed
- 12 Mar 2024
- Value
- £201
- Status
- active
Urgent Palliative Care Medicines · Wells Pharmacy
- Signed
- 12 Mar 2024
- Value
- £201
- Status
- active
Urgent Palliative Care Medicines · Well PharmacySME
- Signed
- 12 Mar 2024
- Value
- £201
- Status
- active
Urgent Palliative Care Medicines · Wells Pharmacy
- Signed
- 12 Mar 2024
- Value
- £201
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Cheshire and Merseyside Integrated Care BoardReview body
Bidders & participating suppliers
4 commercial parties on the notice- Rowlands PharmacyAwarded supplier
- Well PharmacyAwarded supplier
- Wells PharmacyAwarded supplier
- Wells PharmacyAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.